Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens Reports Sale of $74,642.17 in Common Shares

By Public Technologies20:07 (UTC), 23 October 2026 Updated

Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens sold 1,489 common shares at $37.53 on October 21, 2026.
She sold another 500 common shares at $37.52 on October 22, 2026.
Gheuens exercised stock options for 1,989 common shares at $25.01 per share across the two dates.
Following the transactions, she directly held 54,645 common shares and 24,141 stock options.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agios Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001439222-26-000122), on October 23, 2026, and is solely responsible for the information contained therein.